Mapping the genes that predispose to murine lupus

绘制易患小鼠狼疮的基因图谱

基本信息

项目摘要

Summary) )To elucidate the T cell – B cell mechanisms involved lupus pathogenesis, the PI has used an induced model of murine lupus, the parent-into-F1 model of graft-vs.-host disease (GVHD). Using B6D2F1 mice as hosts, DBA/2 (DBA) parental T cell transfers result in lupus specific autoantibodies and lupus nephritis (chronic GVHD) whereas B6 parental T cell donors cause elimination of host B cells and no lupus specific autoantibodies (acute GVHD). The PI has demonstrated that these two divergent outcomes are strongly associated with differential parental CD4 IL-2 production e.g. B6 CD4 T cells are strong IL-2 producers and promote a donor cytotoxic T cell response whereas DBA CD4 T cell IL-2 production is profoundly impaired resulting in skewing towards T follicular helper cells, host B cell activation and autoantibody formation. The BXD Recombinant Inbred (BXDRI) lines are > 100 lines of backcrosses of the B6 and DBA parents that have been successfully used in gene mapping. In an earlier study, the PI and collaborators used a limited number of BXD strains and demonstrated the feasibility of using BXD splenocytes as donors into B6D2F1 mice to induce acute or chronic GVHD. Genetic analysis and mapping tools have advanced significantly since then and the number of BXD strains has nearly tripled. Using the PàF1 model, we propose to: Aim 1. Map the gene variants that predispose to lupus-like cGVHD phenotype. In collaboration with Dr. Robert Williams who has developed many of the new BXDRI lines we will test a larger number of BXD strains as donors into B6D2 mice and map the genes important in chronic GVHD lupus phenotype. Aim 2. Map the sequence variants involved in defective CD4 IL-2 production and determine their linkage to lupus-like cGVHD. In vitro IL-2 production by BXD CD4 T cells will be tested and the genes for the IL-2 defect mapped as well as the concordance between BXD strains that exhibit both defective CD4 IL-2 production in vitro and chronic cGVHD in vivo. These results will address the hypothesis that a primary asymptomatic defect in CD4 IL-2 production in humans could predispose to lupus. Successful mapping of the gene variants that modulate lupus-like GVHD will define new molecular mechanisms, complex networks of interactions among cells and tissues, and define homologous mechanisms with potential applicability to human lupus.
总结)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charles S. Via其他文献

Circumvention of defective CD4 T helper cell function in HIV-infected individuals by stimulation with HLA alloantigens.
通过 HLA 同种抗原刺激来规避 HIV 感染者 CD4 T 辅助细胞功能缺陷。
  • DOI:
    10.4049/jimmunol.144.9.3266
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Mario Clerici;N. Stocks;R. Zajac;R. Boswell;Charles S. Via;G. Shearer
  • 通讯作者:
    G. Shearer

Charles S. Via的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charles S. Via', 18)}}的其他基金

IMMUNOPATHOGENESIS OF LUPUS
狼疮的免疫发病机制
  • 批准号:
    6497379
  • 财政年份:
    2001
  • 资助金额:
    $ 22.87万
  • 项目类别:
IMMUNOPATHOGENESIS OF LUPUS
狼疮的免疫发病机制
  • 批准号:
    6287604
  • 财政年份:
    2001
  • 资助金额:
    $ 22.87万
  • 项目类别:
Immunopathogenesis of Lupus
狼疮的免疫发病机制
  • 批准号:
    8197177
  • 财政年份:
    2001
  • 资助金额:
    $ 22.87万
  • 项目类别:
Immunopathogenesis of Lupus
狼疮的免疫发病机制
  • 批准号:
    7740804
  • 财政年份:
    2001
  • 资助金额:
    $ 22.87万
  • 项目类别:
IMMUNOPATHOGENESIS OF LUPUS
狼疮的免疫发病机制
  • 批准号:
    6845167
  • 财政年份:
    2001
  • 资助金额:
    $ 22.87万
  • 项目类别:
IMMUNOPATHOGENESIS OF LUPUS
狼疮的免疫发病机制
  • 批准号:
    6628074
  • 财政年份:
    2001
  • 资助金额:
    $ 22.87万
  • 项目类别:
IMMUNOPATHOGENESIS OF LUPUS
狼疮的免疫发病机制
  • 批准号:
    6944186
  • 财政年份:
    2001
  • 资助金额:
    $ 22.87万
  • 项目类别:
Immunopathogenesis of Lupus
狼疮的免疫发病机制
  • 批准号:
    7380239
  • 财政年份:
    2001
  • 资助金额:
    $ 22.87万
  • 项目类别:
IMMUNOPATHOGENESIS OF LUPUS
狼疮的免疫发病机制
  • 批准号:
    6700214
  • 财政年份:
    2001
  • 资助金额:
    $ 22.87万
  • 项目类别:
Immunopathogenesis of Lupus
狼疮的免疫发病机制
  • 批准号:
    7534991
  • 财政年份:
    2001
  • 资助金额:
    $ 22.87万
  • 项目类别:

相似海外基金

A Novel Small Molecule Therapeutic for Acute Graft Versus Host Disease
一种治疗急性移植物抗宿主病的新型小分子疗法
  • 批准号:
    10759657
  • 财政年份:
    2023
  • 资助金额:
    $ 22.87万
  • 项目类别:
Investigation of the association between acute graft-versus-host disease and renal impairment.
急性移植物抗宿主病与肾功能损害之间关系的调查。
  • 批准号:
    23K19558
  • 财政年份:
    2023
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Impact of gut mycobiome on acute graft-versus-host disease
肠道真菌组对急性移植物抗宿主病的影响
  • 批准号:
    20K08748
  • 财政年份:
    2020
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Harnessing the single-cell biology and biomarker involving in the therapeutic response of patients with severe acute graft-versus-host disease undergoing mesenchymal stem cell transfusion
利用单细胞生物学和生物标志物参与接受间充质干细胞输注的严重急性移植物抗宿主病患者的治疗反应
  • 批准号:
    19K16605
  • 财政年份:
    2019
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effectiveness of dimethyl fumarate for acute graft-versus-host disease
富马酸二甲酯治疗急性移植物抗宿主病的有效性
  • 批准号:
    19K24001
  • 财政年份:
    2019
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Role of T cells and the Intestinal Microbiota in the Pathogenesis of Acute Graft- versus- Host Disease
T 细胞和肠道微生物群在急性移植物抗宿主病发病机制中的作用
  • 批准号:
    9754362
  • 财政年份:
    2019
  • 资助金额:
    $ 22.87万
  • 项目类别:
Frequency analysis of graft-versus-host reactive T cell clones in human acute graft-versus-host disease tissues
人急性移植物抗宿主病组织中移植物抗宿主反应性T细胞克隆的频率分析
  • 批准号:
    18K08321
  • 财政年份:
    2018
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Prevention of acute Graft-versus-Host disease after allogeneic stem cell transplantation by molecular targeting of anti-apoptotic proteins in activated donor T-cells (A08*)
通过分子靶向活化供体 T 细胞中的抗凋亡蛋白来预防同种异体干细胞移植后的急性移植物抗宿主病 (A08*)
  • 批准号:
    278130007
  • 财政年份:
    2015
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Collaborative Research Centres
Pathological analysis of acute graft-versus-host disease and development of molecular targeted therapy for acute GVHD
急性移植物抗宿主病的病理分析及急性GVHD分子靶向治疗的进展
  • 批准号:
    15K09657
  • 财政年份:
    2015
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Altered Exosomal miRNA expression of late onset acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
异基因造血干细胞移植中迟发型急性移植物抗宿主病外泌体 miRNA 表达的改变。
  • 批准号:
    26860373
  • 财政年份:
    2014
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了